Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01855386 · ClinicalTrials.gov registry record

The Role of Non-Alcoholic Fatty Liver Disease in Gestational Diabetes

A clinical trial, sponsored by University of Florida.

Terminated
Registry status
126
Enrollment target

NCT01855386: Clinical Trial study, sponsored by University of Florida.

NCT01855386 is a clinical trial that was terminated before completion, run by University of Florida. The registered enrollment target is 126 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01855386 was terminated before completion, sponsored by University of Florida.

TERMINATED
Registry status
126 participants
Enrollment target

Study Summary

The thought is that Non-Alcoholic Fatty Liver Disease (NAFLD) plays a key role in the progression to prediabetes/T2DM in those with a history of Gestational Diabetes (GDM). The investigators want to know if having a fatty liver will be connected with more glucose abnormalities (higher fasting/oral glucose tolerance test glucose, more insulin resistance) and that a history of GDM will be common in those with NAFLD.

Primary Outcome

Patients with gestational diabetes will be screened for fatty liver by ultrasound to estimate the prevalence of NAFLD in this population.

Interventions

  • OTHER Subjects with Gestational Diabetes
  • OTHER Controls without Gestational Diabetes

Trial Details

FieldValue
Enrollment Target 126 participants
Start Date 2013-01
Est. Completion 2018-09
University of Florida

1,106 total trials

Why NCT01855386 stopped before completion

NCT01855386 is an observational study that tracks outcomes without assigning an intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 2 interventions - of which Subjects with Gestational Diabetes is the first listed.

NCT01855386 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01855386 about?

NCT01855386 is a clinical study titled "The Role of Non-Alcoholic Fatty Liver Disease in Gestational Diabetes". The thought is that Non-Alcoholic Fatty Liver Disease (NAFLD) plays a key role in the progression to prediabetes/T2DM in those with a history of Gestational Diabetes (GDM). The investigators want to know if having a fatty liver will be connected with more glucose abnormalities (higher fasting/oral g...

What is the current status of trial NCT01855386?

This trial is currently terminated. The enrollment target is 126 participants. The study started on 2013-01. Estimated completion is 2018-09.

What interventions are being tested in trial NCT01855386?

The interventions under investigation include: Subjects with Gestational Diabetes (OTHER), Controls without Gestational Diabetes (OTHER).

Who is sponsoring clinical trial NCT01855386?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01873131 · 126 participants · NA

    A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn

  • NCT02621645 · 126 participants · Phase 4

    TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence

  • NCT03838107 · 126 participants

    Markers of Trajectory in Pediatric CRPS

  • NCT03906422 · 126 participants · NA

    Comparison of Patient-reported Pain After Initial Archwire Placement

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01855386, the US trial registry maintained by the National Library of Medicine. NCT01855386 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.